LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p

Cancer Letters

Volumn 371, Issue 1, 2016, Pages 99-106

  Nie, Wei ^a   Ge, Hui juan ^b   Yang, Xiao qun ^b   Sun, Xiangjie ^b   Huang, Hai ^a   Tao, Xia ^a   Chen, Wan sheng ^a   Li, Bing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

ERBB4; LncRNA; MiR 193a 3p; Non small cell lung cancer; UCA1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 193A 3P; UNCLASSIFIED DRUG; ERBB4 PROTEIN, HUMAN; MIRN193 MICRORNA, HUMAN; UCA1 RNA, HUMAN;

ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; ERBB4 GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC RISK; HUMAN; HUMAN CELL; NON SMALL CELL LUNG CANCER; ONCOGENE; PRIORITY JOURNAL; SURVIVAL TIME; UPREGULATION; UROTHELIAL CARCINOMA ASSOCIATED 1 GENE; CARCINOMA, NON-SMALL-CELL LUNG; CHI SQUARE DISTRIBUTION; FEMALE; GENETIC TRANSFECTION; GENETICS; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; RNA INTERFERENCE; TIME FACTOR; TREATMENT OUTCOME; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONCOGENES; PROPORTIONAL HAZARDS MODELS; RECEPTOR, ERBB-4; RETROSPECTIVE STUDIES; RISK FACTORS; RNA INTERFERENCE; RNA, LONG NONCODING; TIME FACTORS; TRANSFECTION; TREATMENT OUTCOME; UP-REGULATION;

EID: 84951829854     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.11.024     Document Type: Article

References (25)

1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J. Clin 2015, 65:5-29.
2. Chen W., Zheng R., Zeng H., Zhang S., He J. Annual report on status of cancer in China, 2011. Chin. J. Cancer Res 2015, 27:2-12.
3. Janku F., Stewart D.J., Kurzrock R. Targeted therapy in non-small-cell lung cancer - is it becoming a reality?. Nat. Rev. Clin. Oncol 2010, 7:401-414.
4. Ma X.L., Xiao Z.L., Liu L., Liu X.X., Nie W., Li P., et al. Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer. Asian Pac. J. Cancer Prev 2012, 13:1137-1144.
5. Reck M., Heigener D.F., Mok T., Soria J.C., Rabe K.F. Management of non-small-cell lung cancer: recent developments. Lancet 2013, 382:709-719.
6. Wang X.S., Zhang Z., Wang H.C., Cai J.L., Xu Q.W., Li M.Q., et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin. Cancer Res 2006, 12:4851-4858.
7. Fan Y., Shen B., Tan M., Mu X., Qin Y., Zhang F., et al. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J. 2014, 281:1750-1758.
8. Fu X., Liu Y., Zhuang C., Liu L., Cai Z., Huang W. Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637. Mol. Biosyst 2015, 11:1285-1289.
9. Wang T., Yuan J., Feng N., Li Y., Lin Z., Jiang Z., et al. Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer. Tumour Biol 2014, 35:10075-10084.
10. Xue M., Li X., Li Z., Chen W. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1alpha-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion. Tumour Biol 2014, 35:6901-6912.
11. Xue M., Li X., Wu W., Zhang S., Wu S., Li Z., et al. Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein alpha contributes to bladder cancer cell growth and reduced apoptosis. Oncol. Rep 2014, 31:1993-2000.
12. Li Z., Li X., Wu S., Xue M., Chen W. Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci 2014, 105:951-955.
13. Wang F., Ying H.Q., He B.S., Pan Y.Q., Deng Q.W., Sun H.L., et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 2015, 6:7899-7917.
14. Brambilla E., Travis W.D., Colby T.V., Corrin B., Shimosato Y. The new World Health Organization classification of lung tumours. Eur. Respir. J. 2001, 18:1059-1068.
15. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J. Thorac. Oncol 2007, 2:706-714.
16. Nie W., Xu M.D., Gan L., Huang H., Xiu Q., Li B. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer. Lab. Invest 2015, 95:56-64.
17. Karginov F.V., Conaco C., Xuan Z., Schmidt B.H., Parker J.S., Mandel G., et al. A biochemical approach to identifying microRNA targets. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19291-19296.
18. Yu T., Li J., Yan M., Liu L., Lin H., Zhao F., et al. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway. Oncogene 2015, 34:413-423.
19. Liang H., Liu M., Yan X., Zhou Y., Wang W., Wang X., et al. miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4. J. Biol. Chem 2015, 290:926-940.
20. Shi X., Sun M., Liu H., Yao Y., Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013, 339:159-166.
21. Guenzl P.M., Barlow D.P. Macro lncRNAs: a new layer of cis-regulatory information in the mammalian genome. RNA Biol 2012, 9:731-741.
22. Li C.H., Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int. J. Biochem. Cell Biol 2013, 45:1895-1910.
23. Qi P., Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod. Pathol 2013, 26:155-165.
24. Xu M.D., Qi P., Du X. Long non-coding RNAs in colorectal cancer: implications for pathogenesis and clinical application. Mod. Pathol 2014, 27:1310-1320.
25. Liang W.C., Fu W.M., Wong C.W., Wang Y., Wang W.M., Hu G.X., et al. The LncRNA H19 promotes epithelial to mesenchymal transition by functioning as MiRNA sponges in colorectal cancer. Oncotarget 2015, 6:22513-22525.